undamentalytics Newsletter
Sign in

Septerna, Inc. balance sheet

At the end of fiscal 2025, Septerna, Inc. had total assets of $596m, total liabilities of $214m and shareholders' equity of $382m. It held $121m in cash against $0 of debt: net cash of $121m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents8823812185
Receivables001012
Total current assets113357411396
Total assets131457596567
Accounts payable33104
Deferred revenue (current)—06260
Total current liabilities7138779
Total debt0000
Total liabilities2037214180
Shareholders' equity−38420382387
Non-controlling interests and other (assets − liabilities − equity)149———
Net debt (negative = net cash)−88−238−121−85
Shares outstanding——45m46m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: AGIO vs SEPNKYMR vs SEPNSEPN vs XNCRFDMT vs SEPN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Septerna, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Septerna, Inc.